Finding 1136135 (2023-001)

Material Weakness
Requirement
ABCEHLM
Questioned Costs
-
Year
2023
Accepted
2025-05-06
Audit: 355577

AI Summary

  • Core Issue: The trial balance lacked necessary adjusting entries, leading to inaccuracies in financial reporting.
  • Impacted Requirements: Internal controls over financial reporting and GAAP compliance were not met, risking unreliable information for management and governance.
  • Recommended Follow-Up: Review and update the revenue recognition policy to align with GAAP standards.

Finding Text

Criteria: Internal controls over financial reporting include the ability to timely reconcile general ledger accounts and produce accurate and timely financial statements in accordance with generally accepted accounting principles (GAAP) to ensure that useful information is available to management and those charged with governance. Condition: The internally generated trial balance provided for the audit did not include certain adjusting entries. Material audit adjustments were required to correct the balances in net assets with and without donor restrictions, grants receivable, deferred revenue, and revenues Effect: Without fully analyzing and accurately recording transactions, information provided to management or the board of directors may not be accurate. Recommendation: The Organization should evaluate its revenue recognition policy and update them to be in line with GAAP. Views of responsible officials and planned corrective actions: Management acknowledges that adjustments to deferred revenue, receivables, and revenue were required.

Categories

Reporting Internal Control / Segregation of Duties

Other Findings in this Audit

  • 559681 2023-001
    Material Weakness
  • 559682 2023-002
    Significant Deficiency
  • 559683 2023-001
    Material Weakness
  • 559684 2023-002
    Significant Deficiency
  • 559685 2023-001
    Material Weakness
  • 559686 2023-002
    Significant Deficiency
  • 559687 2023-001
    Material Weakness
  • 559688 2023-002
    Significant Deficiency
  • 559689 2023-001
    Material Weakness
  • 559690 2023-002
    Significant Deficiency
  • 559691 2023-001
    Material Weakness
  • 559692 2023-002
    Significant Deficiency
  • 559693 2023-001
    Material Weakness
  • 559694 2023-002
    Significant Deficiency
  • 559695 2023-001
    Material Weakness
  • 559696 2023-002
    Significant Deficiency
  • 1136123 2023-001
    Material Weakness
  • 1136124 2023-002
    Significant Deficiency
  • 1136125 2023-001
    Material Weakness
  • 1136126 2023-002
    Significant Deficiency
  • 1136127 2023-001
    Material Weakness
  • 1136128 2023-002
    Significant Deficiency
  • 1136129 2023-001
    Material Weakness
  • 1136130 2023-002
    Significant Deficiency
  • 1136131 2023-001
    Material Weakness
  • 1136132 2023-002
    Significant Deficiency
  • 1136133 2023-001
    Material Weakness
  • 1136134 2023-002
    Significant Deficiency
  • 1136136 2023-002
    Significant Deficiency
  • 1136137 2023-001
    Material Weakness
  • 1136138 2023-002
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.566 Refugee and Entrant Assistance_state Administered Programs $180,645
93.391 Activities to Support State, Tribal, Local and Territorial (stlt) Health Department Response to Public Health Or Healthcare Crises $74,570
21.027 Coronavirus State and Local Fiscal Recovery Funds $70,382
10.561 State Administrative Matching Grants for the Supplemental Nutrition Assistance Program $36,439
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $35,060